Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Ann Surg Oncol. 2022 Nov 17;30(3):1630–1641. doi: 10.1245/s10434-022-12806-4

Figure 4.

Figure 4.

Effect of various treatments on murine and human pancreatic cancer cell viability. a. Panc02-luc and AsPC-1 cells demonstrated decreased cell viability in the presence of S1PR2 antagonist JTE-013, regardless of presence or absence of TCA. b. Panc02-luc cells demonstrated increased cell viability in the presence of S1P, regardless of presence or absence of FTY720. ***P<0.001, compared to vehicle control.